SCL STEPAN CO
Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics · NYSE · SEC CIK 94049 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY10.0%
TTM net income YoY-90.4%
TTM EPS YoY-90.4%
Revenue 3-yr CAGR1.5%
Net income 3-yr CAGR-56.4%
Margins
Gross margin12.0%
Operating margin0.9%
Net margin0.2%
FCF margin0.2%
EBITDA margin6.0%
Returns
ROE0.4%
ROA0.2%
ROIC (approx.)1.4%
Asset turnover1.05x
Leverage & solvency
Liabilities / assets49.0%
Debt / equity0.52x
Current ratio1.32x
Interest coverage—
Cash quality & payout
Operating cash flow / net income26.52x
Accruals ratio-4.6%
Payout ratio829.6%
Capex / revenue4.3%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $2.33B | $2.18B | $2.33B | $2.77B | $2.35B |
| Cost of revenue | $2.06B | $1.91B | $2.05B | $2.35B | $1.95B |
| Gross profit | $269.89M | $272.21M | $277.60M | $427.07M | $395.81M |
| R&D expense | $34.80M | $33.54M | $35.73M | $40.90M | $38.78M |
| SG&A expense | $90.79M | $98.28M | $93.20M | $102.18M | $92.91M |
| Operating income | $78.55M | $70.48M | $58.61M | $207.34M | $170.78M |
| Interest expense | $30.77M | $33.03M | $29.36M | $17.85M | $10.14M |
| Pretax income | $59.90M | $60.44M | $48.39M | $188.70M | $172.54M |
| Income tax | $13.01M | $10.07M | $8.19M | $41.55M | $34.64M |
| Net income | $46.90M | $50.37M | $40.20M | $147.15M | $137.80M |
| EBITDA | $204.59M | $182.68M | $163.95M | $301.99M | $261.66M |
| EPS (basic) | 2.05 | 2.21 | 1.77 | 6.46 | 6.01 |
| EPS (diluted) | 2.05 | 2.20 | 1.75 | 6.38 | 5.92 |
| Dividends declared per share | 1.55 | 1.51 | 1.47 | 1.37 | 1.25 |
| Weighted avg. shares (diluted) | 22.89M | 22.93M | 22.95M | 23.06M | 23.29M |
| Balance sheet | |||||
| Cash & equivalents | $132.69M | $99.67M | $129.82M | $173.75M | $159.19M |
| Receivables | $387.96M | $388.03M | $422.05M | $436.91M | $419.54M |
| Inventory | $298.83M | $288.72M | $265.56M | $402.53M | $305.54M |
| Current assets | $858.96M | $810.43M | $851.88M | $1.04B | $913.37M |
| PP&E, net | $1.22B | $1.20B | $1.21B | $1.07B | $850.60M |
| Goodwill | $92.57M | $91.37M | $97.44M | $95.92M | $97.19M |
| Intangibles | $39.53M | $42.67M | $52.57M | $58.03M | $60.78M |
| Total assets | $2.36B | $2.30B | $2.36B | $2.43B | $2.07B |
| Current liabilities | $666.49M | $669.03M | $607.87M | $670.65M | $500.48M |
| Short-term debt | $285.74M | $292.81M | $252.90M | $132.11M | $40.72M |
| Long-term debt | $340.98M | $332.63M | $401.25M | $455.03M | $322.86M |
| Total debt | $626.71M | $625.44M | $654.15M | $587.14M | $363.58M |
| Total liabilities | $1.11B | $1.13B | $1.15B | $1.27B | $991.42M |
| Shareholders' equity | $1.24B | $1.17B | $1.22B | $1.17B | $1.07B |
| Net debt | $494.02M | $525.77M | $524.32M | $413.39M | $204.39M |
| Cash flow statement | |||||
| Operating cash flow | $147.88M | $162.05M | $174.88M | $160.76M | $72.14M |
| Capital expenditure | $122.51M | $122.78M | $260.33M | $301.55M | $194.48M |
| Free cash flow | $25.37M | $39.28M | -$85.46M | -$140.79M | -$122.35M |
| Investing cash flow | -$89.05M | -$116.94M | -$258.67M | -$308.09M | -$376.83M |
| Financing cash flow | -$35.44M | -$64.52M | $33.28M | $166.21M | $117.33M |
| Depreciation & amortization | $126.04M | $112.20M | $105.34M | $94.65M | $90.88M |
| Stock-based compensation | $6.00M | $5.35M | $5.74M | $13.85M | $11.72M |
| Dividends paid | $35.03M | $33.95M | $32.87M | $30.57M | $28.08M |
| Share buybacks | — | — | — | $24.95M | $16.97M |
Free plan shows the latest 5 periods; Pro shows all 17 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.